Every time the AI Express, an investor asks a question on the investor interactive platform: The number of new crown infections in Europe and the United States is huge, and nucleic acid testing to accurately find the new crown virus is impossible to popularize. Therefore, Western countries strongly advocate the use of simple home-use new crown antigen detection reagents. An antigen detection kit of Kehua Company has obtained the EU free sales certificate in 2020. Not long ago, the secretary of the board of directors also responded in Interactive Yi: The company’s main products include POCT products, which are instant detection kits. Please answer: Is the new crown antigen detection reagent applied for sale in Europe and the United States, and what is the sales situation in Europe and the United States? Thanks!
Kehua Bio(002022.SZ) said on the investor interaction platform on January 23 that the company has an antigen test kit certified by the European Union, but it is not a household product.
(Article source: Daily Economic News)
Article source: Daily Economic News
Responsible editor: 92
Original title: Kehua Bio: The company has an antigen test kit certified by the EU, but it is not a household product
Solemnly declare: Oriental Fortune.com releases this information for the purpose of disseminating more information and has nothing to do with the position of this site.
report
Scan the QR code to follow
Oriental Fortune official website WeChat
